11-Hydroxyeicosatetraenoics诱导细胞缩在一个enantioselective的方式
Sara A Helal1,2, Ahmed A El-Sherbeni3, Ayman O S El-Kadi1
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Frontiers in pharmacology
|August 27, 2024
概括
11 - 基酸酸 (11-HETE) 类因子通过增加细胞染色体P450 1B1 (CYP1B1) 度来诱导心脏缩. 这项研究揭示了11-HETE.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 从酸中提取的11-基酸酸 (11-HETE) 联体因子,与心血管疾病有关.
- 细胞染色体P450 1B1 (CYP1B1) 是11-HETE形成中的关键酶,其在心血管病理学中的作用已确立.
研究的目的:
- 研究11-HETE反体对人类心肌细胞 (RL-14细胞) 的过度缩作用.
- 确定11-HETE反体与CYP1B1表达和活性之间的关联.
主要方法:
- 人类RL-14心肌细胞用 (R) -或 (S) -11-HETE进行治疗.
- 细胞缩通过RT-PCR和成像进行评估.
- 使用RT-PCR,西斑和酶分析测量了CYP表达 (mRNA和蛋白质) 和CYP1B1活性.
主要成果:
- 无论是 (R) - 和 (S) -11-HETE都诱导了心肌细胞缩和细胞表面积增加.
- (S) - 11-HETE显示出更明显的CYP1B1,CYP1A1,CYP4F2和CYP4A11的上调.
- 11 (((S) -HETE显著增强了CYP1B1的催化活性,这表明了反选择性全激活.
结论:
- 11-HETE反体在人类RL-14细胞中诱导心脏缩.
- 这种效应是由增加的CYP1B1mRNA,蛋白质水平和催化活性介导的.
- 这些发现突出了一个新的机制,将11-HETE与心血管病理生理学联系起来.
更多相关视频
相关概念视频
Target Cell Response to Hormones
3.0K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
145
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
145
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
10.0K
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
10.0K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K


